Moleculin Biotech, Inc. Increase (Decrease) in Accounts Payable
Moleculin Biotech, Inc. (MBRX) reported Increase (Decrease) in Accounts Payable of $829.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- Moleculin Biotech, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$238.00K, a 128.00% decline year-over-year.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.07M, a 57.84% increase year-over-year.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.29M.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$1.48M.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable for fiscal 2025 was $1.33M.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$468.00K, a 216.13% decline from fiscal 2023.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable for fiscal 2023 was $403.00K, a 44.87% decline from fiscal 2022.
- Moleculin Biotech, Inc. increase (decrease) in accounts payable for fiscal 2022 was $731.00K, a 211.06% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $829.00K 10-Q · filed 2026-08-13 | $2.12M derived: sum of 3 quarters · filed 2026-08-13 | $633.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.07M 10-Q · filed 2026-05-14 | $2.35M derived: sum of 2 quarters · filed 2026-05-14 | $871.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.72M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$196.00K derived: sum of 2 quarters · filed 2026-03-18 | $654.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.33M 10-K · filed 2026-03-18 |
| 2025-09-30 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$633.00K derived: sum of 2 quarters · filed 2026-08-13 | $43.00K 10-Q · filed 2025-11-13 | -$477.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $850.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.53M 10-Q · filed 2026-08-13 | $1.01M derived: sum of 3 quarters · filed 2026-08-13 | $723.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $676.00K 10-Q · filed 2026-05-14 | $156.00K derived: sum of 2 quarters · filed 2026-05-14 | -$127.00K derived: sum of 3 quarters · filed 2026-05-14 | $602.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$803.00K derived: sum of 2 quarters · filed 2026-03-18 | -$74.00K derived: sum of 3 quarters · filed 2026-03-18 | -$468.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | -$283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $446.00K derived: sum of 2 quarters · filed 2025-11-13 | $52.00K 10-Q · filed 2025-11-13 | $542.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $729.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $335.00K 10-Q · filed 2025-08-12 | $825.00K derived: sum of 3 quarters · filed 2025-08-12 | -$1.30M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$394.00K 10-Q · filed 2025-05-13 | $96.00K derived: sum of 2 quarters · filed 2025-05-13 | -$2.03M derived: sum of 3 quarters · filed 2025-05-13 | $165.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$1.64M derived: sum of 2 quarters · filed 2025-03-21 | $559.00K derived: sum of 3 quarters · filed 2025-03-21 | $403.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | -$2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $69.00K derived: sum of 2 quarters · filed 2024-11-08 | -$87.00K 10-Q · filed 2024-11-08 | -$1.56M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $2.04M 10-Q · filed 2024-08-13 | $568.00K derived: sum of 3 quarters · filed 2024-08-13 | $952.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$156.00K 10-Q · filed 2024-05-10 | -$1.63M derived: sum of 2 quarters · filed 2024-05-10 | -$1.25M derived: sum of 3 quarters · filed 2024-05-10 | -$285.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$1.09M derived: sum of 2 quarters · filed 2024-03-22 | -$129.00K derived: sum of 3 quarters · filed 2024-03-22 | $731.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.34M derived: sum of 2 quarters · filed 2023-11-13 | $2.20M 10-Q · filed 2023-11-13 | $2.18M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $960.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.82M 10-Q · filed 2023-08-10 | $1.79M derived: sum of 3 quarters · filed 2023-08-10 | $1.68M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $860.00K 10-Q · filed 2023-05-10 | $834.00K derived: sum of 2 quarters · filed 2023-05-10 | $719.00K derived: sum of 3 quarters · filed 2023-05-10 | $296.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$141.00K derived: sum of 2 quarters · filed 2023-03-22 | -$564.00K derived: sum of 3 quarters · filed 2023-03-22 | $235.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | -$115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$538.00K derived: sum of 2 quarters · filed 2022-11-10 | $261.00K 10-Q · filed 2022-11-10 | $47.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$423.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $376.00K 10-Q · filed 2022-08-12 | $162.00K derived: sum of 3 quarters · filed 2022-08-12 | -$413.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $799.00K 10-Q · filed 2022-05-11 | $585.00K derived: sum of 2 quarters · filed 2022-05-11 | $10.00K derived: sum of 3 quarters · filed 2022-05-11 | $722.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$789.00K derived: sum of 2 quarters · filed 2022-03-24 | -$77.00K derived: sum of 3 quarters · filed 2022-03-24 | -$1.02M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$575.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $137.00K derived: sum of 2 quarters · filed 2021-11-10 | -$810.00K 10-Q · filed 2021-11-10 | -$1.84M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $712.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$235.00K 10-Q · filed 2021-08-11 | -$1.27M derived: sum of 3 quarters · filed 2021-08-11 | $661.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$947.00K 10-Q · filed 2021-05-12 | -$1.98M derived: sum of 2 quarters · filed 2021-05-12 | -$51.00K derived: sum of 3 quarters · filed 2021-05-12 | -$1.59M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $896.00K derived: sum of 2 quarters · filed 2021-03-24 | -$646.00K derived: sum of 3 quarters · filed 2021-03-24 | $907.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $389.00K derived: sum of 2 quarters · filed 2020-11-12 | $1.94M 10-Q · filed 2020-11-12 | $2.40M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $11.00K 10-Q · filed 2020-08-12 | $472.00K derived: sum of 3 quarters · filed 2020-08-12 | -$419.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $1.55M 10-Q · filed 2020-05-11 | $2.01M derived: sum of 2 quarters · filed 2020-05-11 | $1.12M derived: sum of 3 quarters · filed 2020-05-11 | $2.23M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$430.00K derived: sum of 2 quarters · filed 2020-03-19 | $675.00K derived: sum of 3 quarters · filed 2020-03-19 | $436.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | -$891.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $214.00K derived: sum of 2 quarters · filed 2019-11-12 | -$25.00K 10-Q · filed 2019-11-12 | -$131.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-16 | $866.00K 10-Q · filed 2019-08-16 | $760.00K derived: sum of 3 quarters · filed 2019-08-16 | $1.28M derived: sum of 4 quarters · filed 2019-08-16 |
| 2018-03-31 | -$239.00K 10-Q · filed 2019-05-13 | -$345.00K derived: sum of 2 quarters · filed 2019-05-13 | $180.00K derived: sum of 3 quarters · filed 2019-05-13 | -$115.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | -$106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $419.00K derived: sum of 2 quarters · filed 2019-02-21 | $124.00K derived: sum of 3 quarters · filed 2019-02-21 | $411.00K 10-K · filed 2019-02-21 |
| 2017-09-30 | $525.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $230.00K derived: sum of 2 quarters · filed 2018-11-13 | $517.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$8.00K 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | $287.00K 10-Q · filed 2018-05-14 | |||
| 2016-12-31 | -$41.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |